SCHEMBL114886

SCHEMBL114886

COC/C=C(\C)CCC=C(C)C

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
ALOX15 P16050 3/20 0.62
ALDH1A1 P00352 2/20 0.62
MEN1 O00255 2/20 0.58
CYP3A4 P08684 2/20 0.58
MAPT P10636 2/20 0.56
UGT1A1 P22309 1/20 0.56
FNTA P49354 5/20 0.54
FNTB P49356 3/20 0.54
PGGT1B P53609 2/20 0.54
SQLE Q14534 3/20 0.54
KDM4E B2RXH2 1/20 0.50
GGPS1 O95749 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL356732 1.00 KMT2A (0.62) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL114887 1.00 KMT2A (0.62) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL11617759 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL15980322 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL12967956 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL1704911 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL15980978 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL15980982 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL10127135 0.98 KMT2A (0.67) KMT2AALOX15ALDH1A1MEN1CYP3A4
SCHEMBL11039524 0.86 SQLE (0.54) KMT2AALOX15ALDH1A1MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12344569-B2 Process for making a conjugated diene from an allyl alcohol GIVAUDAN SA (CH) 2025-07-01 US claimed
WO-2025108540-A1 5-METHYLCYCLOHEXANOLS AND DERIVATIVES AS FRAGRANCES SYMRISE AG (DE) 2025-05-30 WO claimed
CN-118415194-A Natural plant extract essential oil disinfectant for inactivating coronaviruses and preparation method thereof 郭艺茜 2024-08-02 CN claimed
EP-4168383-B1 PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL GIVAUDAN SA (CH) 2024-07-31 EP claimed
CN-117396590-A Perfume for improving relaxation state and evaluation method 奇华顿股份有限公司 2024-01-12 CN claimed
US-20230322645-A1 PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL GIVAUDAN SA (CH) 2023-10-12 US claimed
CN-113387786-B Safener for protecting cereal from herbicide 河南省农业科学院植物保护研究所 2023-08-01 CN claimed
EP-4168383-A1 PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL Givaudan SA (CH) 2023-04-26 EP claimed
CN-115996904-A Process for preparing conjugated dienes from allyl alcohol 奇华顿股份有限公司 2023-04-21 CN claimed
US-20220364016-A1 PERFUME OIL MIXTURE SYMRISE AG (DE) 2022-11-17 US claimed
US-20090162308-A1 USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE SYMRISE GMBH & CO. KG (DE) 2009-06-25 US claimed
EP-2072083-A1 Utilisation of 2.4'-dimethyl-propiophenon as an aroma Symrise GmbH & Co. KG (DE) 2009-06-24 EP claimed
WO-2008104226-A1 FRAGRANCE DISPENSER SYMRISE GMBH & CO. KG (DE) 2008-09-04 WO claimed
US-20060166857-A1 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes SYMRISE GMBH & CO. KG (DE) 2006-07-27 US claimed
EP-1682230-A1 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES Symrise GmbH & Co. KG (DE) 2006-07-26 EP claimed
US-20060040218-A1 Terpene ether solvents WYATT MARION F 2006-02-23 US claimed
WO-2005004825-A1 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES SYMRISE GMBH & CO. KG (DE) 2005-01-20 WO claimed
CN-87103789-A Through improving the polydicyclopentadiene of smell 1988-12-14 CN claimed
US-4731395-A Polydicyclopentadiene having improved odor HERCULES INCORPORATED (US) 1988-03-15 US claimed
EP-0249032-A1 Polydicyclopentadiene having improved odor HERCULES INCORPORATED (US) 1987-12-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12344569-B2 Process for making a conjugated diene from an allyl alcohol ADH1C, ADH1A, ADH5 KMT2A 1850/4885ALOX15 147/4885ALDH1A1 17/4885
US-20090162308-A1 USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE CYP1B1, CYP4A22, ROS1 KMT2A 585/4885ALOX15 522/4885ALDH1A1 17/4885
US-20230322645-A1 PROCESS FOR MAKING A CONJUGATED DIENE FROM AN ALLYL ALCOHOL ADH1C, ADH1A, ADH5 KMT2A 1850/4885ALOX15 147/4885ALDH1A1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.